nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—CYP2D6—Parkinson's disease	0.561	0.583	CbGaD
Fexofenadine—ABCB1—Parkinson's disease	0.4	0.417	CbGaD
Fexofenadine—Lomitapide—ABCB1—Parkinson's disease	0.001	0.115	CrCbGaD
Fexofenadine—Fluspirilene—HTR1A—Parkinson's disease	0.000895	0.102	CrCbGaD
Fexofenadine—Pimozide—DRD3—Parkinson's disease	0.00082	0.0938	CrCbGaD
Fexofenadine—Fluspirilene—DRD2—Parkinson's disease	0.00076	0.0868	CrCbGaD
Fexofenadine—Pimozide—HTR1A—Parkinson's disease	0.000669	0.0765	CrCbGaD
Fexofenadine—Fluspirilene—HTR2A—Parkinson's disease	0.000587	0.0671	CrCbGaD
Fexofenadine—Pimozide—DRD2—Parkinson's disease	0.000568	0.0649	CrCbGaD
Fexofenadine—Pimozide—CYP2E1—Parkinson's disease	0.000546	0.0625	CrCbGaD
Fexofenadine—Darifenacin—CYP2D6—Parkinson's disease	0.000541	0.0619	CrCbGaD
Fexofenadine—Pimozide—HTR2A—Parkinson's disease	0.000439	0.0502	CrCbGaD
Fexofenadine—Pimozide—CYP2D6—Parkinson's disease	0.000401	0.0459	CrCbGaD
Fexofenadine—Loperamide—CYP2D6—Parkinson's disease	0.000335	0.0383	CrCbGaD
Fexofenadine—Pimozide—ABCB1—Parkinson's disease	0.000287	0.0328	CrCbGaD
Fexofenadine—Fentanyl—ABCB1—Parkinson's disease	0.000248	0.0284	CrCbGaD
Fexofenadine—Loperamide—ABCB1—Parkinson's disease	0.000239	0.0273	CrCbGaD
Fexofenadine—Methadone—CYP2D6—Parkinson's disease	0.000238	0.0273	CrCbGaD
Fexofenadine—Methadone—ABCB1—Parkinson's disease	0.00017	0.0195	CrCbGaD
Fexofenadine—SLCO1B1—Metabolism—TALDO1—Parkinson's disease	6.11e-05	0.00202	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—OMD—Parkinson's disease	6.11e-05	0.00202	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—CP—Parkinson's disease	6.04e-05	0.002	CbGpPWpGaD
Fexofenadine—HRH1—G alpha (q) signalling events—HTR2A—Parkinson's disease	6.03e-05	0.00199	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PPP1R1B—Parkinson's disease	5.96e-05	0.00197	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—ADORA2A—Parkinson's disease	5.91e-05	0.00196	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.83e-05	0.00193	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—NDUFB11—Parkinson's disease	5.8e-05	0.00192	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—FBP1—Parkinson's disease	5.76e-05	0.00191	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GBA—Parkinson's disease	5.76e-05	0.00191	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—DBH—Parkinson's disease	5.76e-05	0.00191	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	5.71e-05	0.00189	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	5.7e-05	0.00189	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	5.7e-05	0.00189	CbGpPWpGaD
Fexofenadine—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	5.63e-05	0.00186	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GCH1—Parkinson's disease	5.53e-05	0.00183	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—GRK5—Parkinson's disease	5.44e-05	0.0018	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	5.39e-05	0.00178	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—DDC—Parkinson's disease	5.38e-05	0.00178	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.35e-05	0.00177	CbGpPWpGaD
Fexofenadine—SLCO1B3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	5.13e-05	0.0017	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—HTR1A—Parkinson's disease	5.13e-05	0.0017	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GSTA4—Parkinson's disease	5.08e-05	0.00168	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—TAC1—Parkinson's disease	5.05e-05	0.00167	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.04e-05	0.00167	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	5.02e-05	0.00166	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.99e-05	0.00165	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—DRD1—Parkinson's disease	4.96e-05	0.00164	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—GRK5—Parkinson's disease	4.94e-05	0.00163	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—FBP1—Parkinson's disease	4.93e-05	0.00163	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GBA—Parkinson's disease	4.93e-05	0.00163	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—DBH—Parkinson's disease	4.93e-05	0.00163	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—GRM4—Parkinson's disease	4.88e-05	0.00161	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.83e-05	0.0016	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—DRD3—Parkinson's disease	4.8e-05	0.00159	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	4.73e-05	0.00156	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	4.71e-05	0.00156	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	4.7e-05	0.00155	CbGpPWpGaD
Fexofenadine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	4.67e-05	0.00154	CbGpPWpGaD
Fexofenadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	4.66e-05	0.00154	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VPS35—Parkinson's disease	4.64e-05	0.00154	CbGpPWpGaD
Fexofenadine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	4.64e-05	0.00154	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PENK—Parkinson's disease	4.62e-05	0.00153	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PLA2G6—Parkinson's disease	4.58e-05	0.00151	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	4.56e-05	0.00151	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—MAOB—Parkinson's disease	4.53e-05	0.0015	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	4.49e-05	0.00149	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	4.49e-05	0.00148	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	4.48e-05	0.00148	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—GRM4—Parkinson's disease	4.43e-05	0.00146	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	4.42e-05	0.00146	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—HTR7—Parkinson's disease	4.34e-05	0.00144	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—DRD2—Parkinson's disease	4.34e-05	0.00144	CbGpPWpGaD
Fexofenadine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	4.33e-05	0.00143	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	4.31e-05	0.00143	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.31e-05	0.00142	CbGpPWpGaD
Fexofenadine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	4.27e-05	0.00141	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—DDC—Parkinson's disease	4.23e-05	0.0014	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PDYN—Parkinson's disease	4.23e-05	0.0014	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.2e-05	0.00139	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PENK—Parkinson's disease	4.2e-05	0.00139	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.13e-05	0.00137	CbGpPWpGaD
Fexofenadine—SLCO1A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.03e-05	0.00133	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GSTA4—Parkinson's disease	3.99e-05	0.00132	CbGpPWpGaD
Fexofenadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	3.99e-05	0.00132	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.94e-05	0.0013	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—GRM5—Parkinson's disease	3.93e-05	0.0013	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	3.93e-05	0.0013	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—DGKQ—Parkinson's disease	3.85e-05	0.00127	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GPR37—Parkinson's disease	3.85e-05	0.00127	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PDYN—Parkinson's disease	3.84e-05	0.00127	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—DDC—Parkinson's disease	3.62e-05	0.0012	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PLA2G6—Parkinson's disease	3.6e-05	0.00119	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.59e-05	0.00119	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—GRM5—Parkinson's disease	3.57e-05	0.00118	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—MAOB—Parkinson's disease	3.56e-05	0.00118	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PPP1R1B—Parkinson's disease	3.52e-05	0.00116	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—EDN1—Parkinson's disease	3.48e-05	0.00115	CbGpPWpGaD
Fexofenadine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.45e-05	0.00114	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTA4—Parkinson's disease	3.42e-05	0.00113	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.39e-05	0.00112	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.37e-05	0.00112	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CYP2D6—Parkinson's disease	3.37e-05	0.00111	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—ADORA2A—Parkinson's disease	3.34e-05	0.00111	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CTGF—Parkinson's disease	3.31e-05	0.00109	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	3.29e-05	0.00109	CbGpPWpGaD
Fexofenadine—ABCB1—Allograft Rejection—TNF—Parkinson's disease	3.26e-05	0.00108	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MCCC1—Parkinson's disease	3.26e-05	0.00108	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ND3—Parkinson's disease	3.26e-05	0.00108	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CYP2E1—Parkinson's disease	3.08e-05	0.00102	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RIT2—Parkinson's disease	3.08e-05	0.00102	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PLA2G6—Parkinson's disease	3.08e-05	0.00102	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	3.07e-05	0.00101	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ND3—Parkinson's disease	3.07e-05	0.00101	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—TALDO1—Parkinson's disease	3.06e-05	0.00101	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—OMD—Parkinson's disease	3.06e-05	0.00101	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—NQO1—Parkinson's disease	3.05e-05	0.00101	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—MAOB—Parkinson's disease	3.04e-05	0.00101	CbGpPWpGaD
Fexofenadine—HRH1—GPCR ligand binding—HTR2A—Parkinson's disease	3.04e-05	0.00101	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—ADORA2A—Parkinson's disease	3.03e-05	0.001	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	3.03e-05	0.001	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—TH—Parkinson's disease	3e-05	0.000993	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GRK5—Parkinson's disease	2.92e-05	0.000964	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NDUFB11—Parkinson's disease	2.9e-05	0.00096	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—HTR1A—Parkinson's disease	2.9e-05	0.000959	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.9e-05	0.000958	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	2.88e-05	0.000954	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—OMD—Parkinson's disease	2.88e-05	0.000954	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CYCS—Parkinson's disease	2.88e-05	0.000953	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—TAC1—Parkinson's disease	2.86e-05	0.000944	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—DRD1—Parkinson's disease	2.8e-05	0.000926	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GCH1—Parkinson's disease	2.77e-05	0.000915	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	2.73e-05	0.000904	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	2.71e-05	0.000897	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CYP2D6—Parkinson's disease	2.65e-05	0.000875	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	2.63e-05	0.000871	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GRM4—Parkinson's disease	2.62e-05	0.000865	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GCH1—Parkinson's disease	2.61e-05	0.000863	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CTGF—Parkinson's disease	2.6e-05	0.000859	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	2.59e-05	0.000858	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—COMT—Parkinson's disease	2.55e-05	0.000844	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	2.54e-05	0.000841	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GSTP1—Parkinson's disease	2.54e-05	0.00084	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—MAOA—Parkinson's disease	2.53e-05	0.000838	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.53e-05	0.000838	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—HMOX1—Parkinson's disease	2.51e-05	0.000829	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PENK—Parkinson's disease	2.48e-05	0.00082	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAG—Parkinson's disease	2.48e-05	0.00082	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GBA—Parkinson's disease	2.47e-05	0.000816	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—FBP1—Parkinson's disease	2.47e-05	0.000816	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—DBH—Parkinson's disease	2.47e-05	0.000816	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	2.46e-05	0.000815	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	2.45e-05	0.000811	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	2.45e-05	0.000811	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CYP2E1—Parkinson's disease	2.42e-05	0.0008	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ABCB1—Parkinson's disease	2.4e-05	0.000795	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—NQO1—Parkinson's disease	2.39e-05	0.000791	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—TH—Parkinson's disease	2.36e-05	0.00078	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GSTM1—Parkinson's disease	2.33e-05	0.000772	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GBA—Parkinson's disease	2.32e-05	0.000769	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—FBP1—Parkinson's disease	2.32e-05	0.000769	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—DBH—Parkinson's disease	2.32e-05	0.000769	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	2.3e-05	0.000761	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PDYN—Parkinson's disease	2.27e-05	0.00075	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CYCS—Parkinson's disease	2.26e-05	0.000749	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CYP2D6—Parkinson's disease	2.26e-05	0.000748	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—GPX1—Parkinson's disease	2.24e-05	0.000739	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	2.23e-05	0.000737	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	2.23e-05	0.000737	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CTGF—Parkinson's disease	2.22e-05	0.000735	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	2.21e-05	0.000731	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.16e-05	0.000713	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GFAP—Parkinson's disease	2.13e-05	0.000705	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GRM5—Parkinson's disease	2.11e-05	0.000697	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.07e-05	0.000684	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CYP2E1—Parkinson's disease	2.07e-05	0.000684	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—MTHFR—Parkinson's disease	2.06e-05	0.000682	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—NQO1—Parkinson's disease	2.05e-05	0.000677	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	2.03e-05	0.000672	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—TH—Parkinson's disease	2.02e-05	0.000667	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—COMT—Parkinson's disease	2.01e-05	0.000663	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GSTP1—Parkinson's disease	2e-05	0.00066	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—MAOA—Parkinson's disease	1.99e-05	0.000659	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—HMOX1—Parkinson's disease	1.97e-05	0.000651	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	1.96e-05	0.000649	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CYCS—Parkinson's disease	1.94e-05	0.00064	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—APOE—Parkinson's disease	1.92e-05	0.000635	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ABCB1—Parkinson's disease	1.89e-05	0.000625	CbGpPWpGaD
Fexofenadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.87e-05	0.000619	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGF20—Parkinson's disease	1.85e-05	0.000611	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GSTM1—Parkinson's disease	1.83e-05	0.000607	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—DDC—Parkinson's disease	1.81e-05	0.000599	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.8e-05	0.000595	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	1.79e-05	0.000593	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	1.78e-05	0.00059	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—GPX1—Parkinson's disease	1.76e-05	0.000581	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.72e-05	0.000568	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—COMT—Parkinson's disease	1.71e-05	0.000567	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTA4—Parkinson's disease	1.71e-05	0.000566	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTP1—Parkinson's disease	1.71e-05	0.000564	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—DDC—Parkinson's disease	1.71e-05	0.000564	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—MAOA—Parkinson's disease	1.7e-05	0.000563	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—HMOX1—Parkinson's disease	1.68e-05	0.000557	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—INSR—Parkinson's disease	1.65e-05	0.000547	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—INS—Parkinson's disease	1.64e-05	0.000543	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—MTHFR—Parkinson's disease	1.62e-05	0.000536	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ABCB1—Parkinson's disease	1.62e-05	0.000534	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.61e-05	0.000533	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	1.61e-05	0.000531	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTM1—Parkinson's disease	1.57e-05	0.000519	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGB—Parkinson's disease	1.56e-05	0.000517	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	1.56e-05	0.000516	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	1.56e-05	0.000514	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.54e-05	0.000509	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	1.53e-05	0.000507	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MAOB—Parkinson's disease	1.52e-05	0.000504	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—APOE—Parkinson's disease	1.51e-05	0.000499	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	1.5e-05	0.000497	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GPX1—Parkinson's disease	1.5e-05	0.000497	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	1.46e-05	0.000481	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.45e-05	0.00048	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.44e-05	0.000475	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—MTHFR—Parkinson's disease	1.39e-05	0.000458	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	1.36e-05	0.000449	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	1.32e-05	0.000435	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	1.32e-05	0.000435	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—APOE—Parkinson's disease	1.29e-05	0.000427	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—INS—Parkinson's disease	1.29e-05	0.000426	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.13e-05	0.000375	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CTGF—Parkinson's disease	1.11e-05	0.000368	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	1.1e-05	0.000365	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—INS—Parkinson's disease	1.1e-05	0.000365	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	1.07e-05	0.000353	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	1.05e-05	0.000348	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.05e-05	0.000347	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.04e-05	0.000343	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NQO1—Parkinson's disease	1.02e-05	0.000339	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—TH—Parkinson's disease	1.01e-05	0.000334	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	9.76e-06	0.000323	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYCS—Parkinson's disease	9.69e-06	0.000321	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NGF—Parkinson's disease	9.68e-06	0.00032	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NQO1—Parkinson's disease	9.65e-06	0.000319	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—TH—Parkinson's disease	9.51e-06	0.000315	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	9.22e-06	0.000305	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYCS—Parkinson's disease	9.13e-06	0.000302	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—COMT—Parkinson's disease	8.59e-06	0.000284	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APOE—Parkinson's disease	8.57e-06	0.000283	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTP1—Parkinson's disease	8.54e-06	0.000283	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MAOA—Parkinson's disease	8.52e-06	0.000282	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HMOX1—Parkinson's disease	8.43e-06	0.000279	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—COMT—Parkinson's disease	8.09e-06	0.000268	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	8.05e-06	0.000266	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MAOA—Parkinson's disease	8.03e-06	0.000266	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	7.94e-06	0.000263	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTM1—Parkinson's disease	7.85e-06	0.00026	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	7.62e-06	0.000252	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GPX1—Parkinson's disease	7.52e-06	0.000249	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	7.4e-06	0.000245	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—INS—Parkinson's disease	7.32e-06	0.000242	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GPX1—Parkinson's disease	7.09e-06	0.000234	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MTHFR—Parkinson's disease	6.94e-06	0.000229	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	6.54e-06	0.000216	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOE—Parkinson's disease	6.46e-06	0.000214	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOE—Parkinson's disease	6.09e-06	0.000201	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—INS—Parkinson's disease	5.52e-06	0.000183	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	5.45e-06	0.00018	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	5.41e-06	0.000179	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—INS—Parkinson's disease	5.2e-06	0.000172	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	5.01e-06	0.000166	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6—Parkinson's disease	3.2e-06	0.000106	CbGpPWpGaD
